Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CORRECTION: Guardant Health Q3 Adj. EPS $(0.39) Beats $(0.77) Estimate, Sales $265.196M Beat $235.692M Estimate

Author: Benzinga Newsdesk | October 29, 2025 05:04pm
Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.77) by 49.02 percent. This is a 13.33 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $265.196 million which beat the analyst consensus estimate of $235.692 million by 12.52 percent. This is a 38.50 percent increase over sales of $191.476 million the same period last year.

Posted In: GH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist